Multipotent mesenchymal stromal cell therapy and risk of malignancies. - Wikidata - wikimedia - TriplyDB

Multipotent mesenchymal stromal cell therapy and risk of malignancies.

Multipotent mesenchymal stromal cell therapy and risk of malignancies.

http://www.wikidata.org/entity/Q37975113

about

Sepsis: From Pathophysiology to Individualized Patient Care Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients Concise review: therapeutic potential of adipose tissue-derived angiogenic cells A review on the use of cell therapy in the treatment of tendon disease and injuries Therapeutic Development of Mesenchymal Stem Cells or Their Extracellular Vesicles to Inhibit Autoimmune-Mediated Inflammatory Processes in Systemic Lupus Erythematosus.Concise Review: Mesenchymal Stromal Cell-Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes.Chromosomal stability of mesenchymal stromal cells during in vitro culture.Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells.An enzymatic method to rescue mesenchymal stem cells from clotted bone marrow samples From bench to bedside: use of human adipose-derived stem cells.Safety and Potential Effect of a Single Intracavernous Injection of Autologous Adipose-Derived Regenerative Cells in Patients with Erectile Dysfunction Following Radical Prostatectomy: An Open-Label Phase I Clinical Trial.Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: lessons learned from first clinical trials.The advancing field of cell-based therapy: insights and lessons from clinical trials.Adult human mesenchymal stromal cells and the treatment of graft versus host disease.First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial.The current landscape of adipose-derived stem cells in clinical applications.Caveats of mesenchymal stem cell therapy in solid organ transplantation.Rationale for the potential use of mesenchymal stromal cells in liver transplantation.The role of stem cell therapies in degenerative lumbar spine disease: a review.Australasian College of Sports Physicians-position statement: the place of mesenchymal stem/stromal cell therapies in sport and exercise medicine.Insurance approval of mesenchymal stem cell for acute GVHD in Japan: need of follow up for some remaining concerns.Mesenchymal Stem Cell-Derived Microvesicles Modulate Lipopolysaccharides-Induced Inflammatory Responses to Microglia Cells.Inflammatory Chemokines MIP-1δ and MIP-3α Are Involved in the Migration of Multipotent Mesenchymal Stromal Cells Induced by Hepatoma Cells.The Safety and Efficacy of Cell-Assisted Fat Grafting to Traditional Fat Grafting in the Anterior Mid-Face: An Indirect Assessment by 3D Imaging.Adoptive cell transfer in autoimmune hepatitis.The Current Status of Stem-Cell Therapy in Erectile Dysfunction: A Review.Characteristics of human adipose mesenchymal stem cells isolated from healthy and cancer affected people and their interactions with human breast cancer cell line MCF-7 in vitro.Accumulation of spontaneous γH2AX foci in long-term cultured mesenchymal stromal cells.Adipose-derived stem cells in orthopaedic pathologies.(Mesenchymal) Stem Cell-Based Therapy in Cisplatin-Induced Acute Kidney Injury Animal Model: Risk of Immunogenicity and Tumorigenicity.Mesenchymal Stromal Cells for AKI after Cardiac Surgery.Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial.Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study

P2860

Q26799911-E36FEFCB-7036-4BE1-A1A9-DC1679B6508F Q26799916-87A43AD4-E011-4202-AC45-F3445DAE3466 Q26998587-2607E8E2-09F2-48CA-884C-DAE30F025D34 Q28251262-7B72BB2E-C6B8-40C9-886B-C57AAD3E58F1 Q33653621-CF253C42-6308-4FA7-ADD7-F28F2BC78EC2 Q33722631-3DE45D1B-2D47-4D9B-AD91-3D06C29E09B4 Q33917128-EC75B40F-B7F7-4DBC-99E7-AA5C2525A90B Q34753440-C793FEE4-46C6-49A4-924E-7547148FECCF Q35037638-11E59E2B-5CF6-4C8F-8152-F0738DC44D2F Q35970592-F210723E-1E8D-44CF-96BE-DDA806E84AA8 Q36257063-00A8E12D-B07B-424A-B5BD-802A73661E29 Q36753915-FBBAA426-B9BE-40C7-A19B-681DA5B2EE53 Q37079961-84D75D90-A8E2-41F6-9A17-54D03B982F60 Q37328786-DAA744A0-F154-44E7-B32C-A6A9FE4DB2DB Q37622055-ECF6A983-BA65-4795-931F-A168B3426CA7 Q37686456-BC053884-B3D2-47D1-8599-3289A6E10D4C Q38210142-06C48576-3EB9-4EBB-9F49-67FC35176015 Q38235872-4B09D3E0-1361-4358-936B-A9F4BD6FD718 Q38282065-B64F4A1B-2E42-4651-B49C-8EC4E4D71D99 Q38370139-456818C2-15E8-4A36-803A-32A12B61143B Q38678597-FCC3C587-29C0-4FD3-B597-3F6B53BE5B6C Q38694213-FD148441-8667-4EDF-90A4-B0D66A7C25AD Q38730368-F86CAA06-318D-47B8-95A2-4D279B0166CB Q38921024-DE2D5B00-FE9F-48D7-B599-B60E84461504 Q38967828-63C17DF4-AA71-47FC-B143-EBB180BBBEEE Q39035161-FC5D6398-4C82-4709-A33D-8630E8339570 Q39067832-951B5F34-CEA2-434D-ACDE-C2B0D04232EA Q39071952-7B02A12C-DEB8-4FC0-910E-080842329AB3 Q42017548-AB214188-EFD8-4348-AE92-6418EFF1393A Q47290431-C45B84CB-1185-42C5-8357-06C15F3FFAE8 Q47706038-67FC57DE-3BE1-4B4C-839A-F3A91FB5AE1B Q48139400-6EF4514D-2B13-4689-8696-AA0FC8BD4B26 Q52668825-91981C3C-812B-4E28-B3C6-EBF40B419041 Q59135921-429F7934-A835-4845-92AB-D243B4B8A7A8

P2860

Multipotent mesenchymal stromal cell therapy and risk of malignancies.

http://www.wikidata.org/entity/Q37975113

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Multipotent mesenchymal stromal cell therapy and risk of malignancies.

@en

Multipotent mesenchymal stromal cell therapy and risk of malignancies.

@nl

type

label

Multipotent mesenchymal stromal cell therapy and risk of malignancies.

@en

Multipotent mesenchymal stromal cell therapy and risk of malignancies.

@nl

prefLabel

Multipotent mesenchymal stromal cell therapy and risk of malignancies.

@en

Multipotent mesenchymal stromal cell therapy and risk of malignancies.

@nl

P1433

Q37975113-6C6B054B-7320-4F58-9B90-34A46CD0F9C2

P1476

Q37975113-1221A841-D571-4E65-928E-652A2C7EB070

P2093

Q37975113-B189C05C-AFD1-4393-9A17-84116E9BABCE

Q37975113-B54293EC-2B9E-4B88-B7BD-5DD1CCCB256F

Q37975113-E90FD4D6-0E57-47BA-BF62-95B0F8EF129F

P2860

Q37975113-0122ABCA-9E75-4F55-B844-B7A3B22DDB8C

Q37975113-033E6C53-1824-4C04-AA27-EC4DB7C58C0F

Q37975113-03BAE91D-6EE8-4C1C-A870-9631F485E30D

Q37975113-07B35772-FE5C-417D-90D3-89872F1DA60E

Q37975113-0FED54B1-63C0-4BF3-9747-4301E02A149F

Q37975113-0FF7E942-5C6C-48C9-A1BB-B8AD7892A548

Q37975113-11BBF0BD-5DFB-4519-A243-1DEB2F3774E8

Q37975113-14A9F6B3-98B0-413E-9EA6-758FD984801E

Q37975113-192B05B3-BD8B-4A46-89A0-A90015752E66

Q37975113-1A8441D4-3523-4C9F-8585-F9E111DA9DF7

P2888

Q37975113-764DB461-FEA7-47BA-8DF1-D7C018B90076

P304

Q37975113-1482CBA7-592C-4828-B26B-B73AFCCA2616

P31

Q37975113-C7FD79E5-6147-434C-B528-AA4D6597BDFC

P356

Q37975113-1DC60578-40F9-497D-8F1B-0ABD621BB899

P433

Q37975113-EF9378CC-752D-4302-AE09-4E7E75A77F74

P478

Q37975113-552DD6B3-F521-481A-BD5A-91F104810CF7

P50

Q37975113-68A3EE82-8873-4FA2-B1AB-D4295DE27BCC

P577

Q37975113-F310EC90-DD4B-491A-9878-0DE13E9C5BDE

P698

Q37975113-8CB55D02-2CC6-454F-AC63-DB18BAA79B39

P356

S12015-011-9345-4

P1433

Stem Cell Reviews and Reports

P1476

Multipotent mesenchymal stromal cell therapy and risk of malignancies.

@en

P2093

Federica Casiraghi

http://www.w3.org/2001/XMLSchema#string

Mauro Abbate

http://www.w3.org/2001/XMLSchema#string

Norberto Perico

http://www.w3.org/2001/XMLSchema#string

P2860

Multilineage potential of adult human mesenchymal stem cells

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Putting tumours in context

Mesenchymal stem cells in health and disease

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

Mesenchymal stem cells

Mesenchymal stem cells and adipogenesis in hemangioma involution.

Molecular characterization of spontaneous mesenchymal stem cell transformation

P2888

s12015-011-9345-4

P304

65-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12015-011-9345-4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Remuzzi

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22237468

http://www.w3.org/2001/XMLSchema#string